A Novel Approach to Targeting DLL3 with Tarlatamab in a Patient with Medullary Thyroid Carcinoma after Progression on Selpercatinib.
Saved in:
| Title: | A Novel Approach to Targeting DLL3 with Tarlatamab in a Patient with Medullary Thyroid Carcinoma after Progression on Selpercatinib. |
|---|---|
| Authors: | Roberts TJ; Department of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Mass General Brigham Cancer Institute, Boston, Massachusetts, USA., Meador CB; Department of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Mass General Brigham Cancer Institute, Boston, Massachusetts, USA., Fuld AD; Dartmouth Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.; Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA., Lasko A; Mass General Brigham Cancer Institute, Boston, Massachusetts, USA., Frigault M; Department of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Mass General Brigham Cancer Institute, Boston, Massachusetts, USA., Hangar KM; Mass General Brigham Cancer Institute, Boston, Massachusetts, USA., Reynolds K; Department of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Mass General Brigham Cancer Institute, Boston, Massachusetts, USA., Sadow PM; Harvard Medical School, Boston, Massachusetts, USA.; Mass General Brigham Cancer Institute, Boston, Massachusetts, USA.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA., Wirth LJ; Department of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Mass General Brigham Cancer Institute, Boston, Massachusetts, USA. |
| Source: | Thyroid : official journal of the American Thyroid Association [Thyroid] 2026 Jun; Vol. 36 (6), pp. 682-687. Date of Electronic Publication: 2026 May 12. |
| Publication Type: | Journal Article; Case Reports |
| Journal Info: | Publisher: Mary Ann Liebert Publishers Country of Publication: United States NLM ID: 9104317 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-9077 (Electronic) Linking ISSN: 10507256 NLM ISO Abbreviation: Thyroid Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!